Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
TScan Therapeutics, Inc. (TCRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
SC 13G
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 9.4% stake in TScan Therapeutics, Inc. |
| 06/02/2023 |
SC 13G
| Lynx1 Capital Management LP reports a 12.2% stake in TScan Therapeutics, Inc. |
| 09/30/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2022 |
SC 13G
| Deer IX & Co. Ltd. reports a 6.7% stake in TScan Therapeutics, Inc. |
| 02/14/2022 |
SC 13G
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. reports a 6.9% stake in TScan Therapeutics, Inc. |
| 02/14/2022 |
SC 13G
| GV 2017, L.P. reports a 5.8% stake in TScan Therapeutics, Inc. |
| 02/14/2022 |
SC 13G
| Pitango HealthTech Fund I, L.P. reports a 4.6% stake in TScan Therapeutics, Inc. |
| 02/10/2022 |
SC 13G
| Longwood Fund IV, L.P. reports a 12.4% stake in TSCAN THERAPEUTICS, INC. |
| 02/04/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/28/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
|
|